Patriot Financial Group Insurance Agency’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,225
| Closed | -$91.9K | – | 478 |
|
|
2023
Q4 | $91.9K | Sell |
10,225
-3,450
| -25% | -$31K | 0.02% | 447 |
|
|
2023
Q3 | $106K | Sell |
13,675
-650
| -5% | -$5.05K | 0.02% | 438 |
|
|
2023
Q2 | $139K | Sell |
14,325
-3,250
| -18% | -$31.5K | 0.03% | 443 |
|
|
2023
Q1 | $193K | Buy |
17,575
+750
| +4% | +$8.22K | 0.04% | 426 |
|
|
2022
Q4 | $72.7K | Hold |
16,825
| – | – | 0.01% | 411 |
|
|
2022
Q3 | $127K | Sell |
16,825
-29,050
| -63% | -$219K | 0.03% | 377 |
|
|
2022
Q2 | $461K | Sell |
45,875
-4,100
| -8% | -$41.2K | 0.09% | 214 |
|
|
2022
Q1 | $619K | Sell |
49,975
-34,775
| -41% | -$431K | 0.11% | 203 |
|
|
2021
Q4 | $1.94M | Buy |
84,750
+13,675
| +19% | +$313K | 0.32% | 57 |
|
|
2021
Q3 | $1.57M | Buy |
71,075
+6,975
| +11% | +$154K | 0.28% | 76 |
|
|
2021
Q2 | $831K | Buy |
64,100
+6,425
| +11% | +$83.3K | 0.15% | 146 |
|
|
2021
Q1 | $749K | Buy |
57,675
+29,900
| +108% | +$388K | 0.17% | 138 |
|
|
2020
Q4 | $384K | Buy |
27,775
+18,075
| +186% | +$250K | 0.1% | 215 |
|
|
2020
Q3 | $143K | Sell |
9,700
-250
| -3% | -$3.69K | 0.05% | 328 |
|
|
2020
Q2 | $162K | Sell |
9,950
-1,900
| -16% | -$30.9K | 0.06% | 267 |
|
|
2020
Q1 | $172K | Buy |
11,850
+7,200
| +155% | +$105K | 0.08% | 233 |
|
|
2019
Q4 | $94K | Sell |
4,650
-14,500
| -76% | -$293K | 0.04% | 349 |
|
|
2019
Q3 | $102K | Buy |
19,150
+4,300
| +29% | +$22.9K | 0.05% | 303 |
|
|
2019
Q2 | $95K | Hold |
14,850
| – | – | 0.04% | 321 |
|
|
2019
Q1 | $97K | Sell |
14,850
-2,000
| -12% | -$13.1K | 0.05% | 275 |
|
|
2018
Q4 | $115K | Sell |
16,850
-3,150
| -16% | -$21.5K | 0.08% | 187 |
|
|
2018
Q3 | $133K | Buy |
20,000
+7,800
| +64% | +$51.9K | 0.08% | 157 |
|
|
2018
Q2 | $69K | Hold |
12,200
| – | – | 0.07% | 155 |
|
|
2018
Q1 | $62K | Buy |
12,200
+1,100
| +10% | +$5.59K | 0.05% | 280 |
|
|
2017
Q4 | $57K | Buy |
+11,100
| New | +$57K | 0.04% | 275 |
|